Td Asset Management Inc Kymera Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 206,894 shares of KYMR stock, worth $8.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

206,894

Previous 218,804 5.44%

Holding current value

$8.14 Million

Previous $6.53 Million 49.93%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$30.16 - $52.4 $359,205 - $624,084	-11,910 Reduced 5.44%	206,894 $9.79 Million
Q1 2024 May 08, 2024	BUY	$22.9 - $43.57 $740,173 - $1.41 Million	32,322 Added 17.33%	218,804 $8.8 Million
Q4 2023 Feb 12, 2024	BUY	$10.97 - $26.84 $26,328 - $64,416	2,400 Added 1.3%	186,482 $4.75 Million
Q3 2023 Oct 27, 2023	BUY	$13.9 - $23.88 $1.17 Million - $2.01 Million	84,167 Added 84.24%	184,082 $2.56 Million
Q2 2023 Aug 09, 2023	BUY	$22.4 - $34.92 $132,160 - $206,028	5,900 Added 6.28%	99,915 $2.3 Million
Q1 2023 May 10, 2023	BUY	$24.84 - $38.75 $360,180 - $561,875	14,500 Added 18.24%	94,015 $2.79 Million
Q4 2022 Feb 06, 2023	BUY	$19.57 - $30.92 $17,613 - $27,828	900 Added 1.14%	79,515 $1.98 Million
Q3 2022 Nov 07, 2022	BUY	$20.91 - $34.27 $40,544 - $66,449	1,939 Added 2.53%	78,615 $1.74 Million
Q2 2022 Aug 04, 2022	SELL	$14.13 - $42.55 $95,886 - $288,744	-6,786 Reduced 8.13%	76,676 $1.51 Million
Q1 2022 May 10, 2022	SELL	$35.3 - $64.68 $171,487 - $314,215	-4,858 Reduced 5.5%	83,462 $3.53 Million
Q4 2021 Feb 10, 2022	BUY	$49.91 - $65.56 $1.02 Million - $1.33 Million	20,355 Added 29.95%	88,320 $5.61 Million
Q3 2021 Nov 09, 2021	BUY	$47.8 - $66.66 $157,740 - $219,978	3,300 Added 5.1%	67,965 $3.99 Million
Q2 2021 Aug 11, 2021	BUY	$31.08 - $51.95 $1.18 Million - $1.98 Million	38,066 Added 143.11%	64,665 $3.89 Million
Q1 2021 May 14, 2021	BUY	$35.64 - $85.46 $128,232 - $307,485	3,598 Added 15.64%	26,599 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $22,456 - $70,264	800 Added 3.6%	23,001 $1.43 Million
Q3 2020 Nov 10, 2020	BUY	$26.1 - $33.28 $579,446 - $738,849	22,201 New	22,201 $717,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.15B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Kymera Therapeutics, Inc. Transaction History